111 – 120 of 363
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Characteristics of subjective cognitive decline associated with amyloid positivity
- Contribution to journal › Article
-
Mark
The future of clinical trials for Alzheimer's disease. A blood-based biomarker perspective
(2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Self- and Partner-Reported Subjective Memory Complaints : Association with Objective Cognitive Impairment and Risk of Decline
- Contribution to journal › Article
-
Mark
Neuropsychological and Neuroanatomical Features of Patients with Behavioral/Dysexecutive Variant Alzheimer's Disease (AD) : A Comparison to Behavioral Variant Frontotemporal Dementia and Amnestic AD Groups
- Contribution to journal › Article
-
Mark
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
- Contribution to journal › Scientific review
-
Mark
Biweekly fluctuations of neuropsychiatric symptoms according to the Neuropsychiatric Inventory : Erratic symptoms or scores?
- Contribution to journal › Article
-
Mark
Progression models for repeated measures : Estimating novel treatment effects in progressive diseases
- Contribution to journal › Article
- 2021
-
Mark
Content-specific vulnerability of recent episodic memories in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Tau PET correlates with different Alzheimer’s disease-related features compared to CSF and plasma p-tau biomarkers
- Contribution to journal › Article
-
Mark
The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau
- Contribution to journal › Article
